Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|January 19, 2010
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLEBridget Griffiths, Paul Emery, Vicky Ryan, et al.
Arthritis Research & Therapy|December 17, 2005
Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3BAnn W Morgan, Jennifer H Barrett, Bridget Griffiths, et al.
Rheumatology (Oxford, England)|June 10, 2022
The BILAG-2004 index is associated with development of new damage in SLEChee-Seng Yee, Caroline Gordon, Mohammed Akil, et al.
Rheumatology (Oxford, England)|December 8, 2020
BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UKFiona A Pearce, Megan Rutter, Ravinder Sandhu, et al.
Rheumatology (Oxford, England)|March 7, 2021
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosusMegan Rutter, Peter C Lanyon, Ravinder Sandhu, et al.
Rheumatology (Oxford, England)|February 24, 2018
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activityIris L A Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, et al.
The Journal of Rheumatology|December 4, 2009
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) studySahena Haque, Caroline Gordon, David Isenberg, et al.
Human Molecular Genetics|April 6, 2017
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICARaphael Carapito, Jacques-Eric Gottenberg, Irina Kotova, et al.
Rheumatology (Oxford, England)|February 24, 2026
A randomised open label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot)Christopher P Denton, Philip Yee, Medha Kanitkar, et al.
Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Pageof 7